The HEAL ETF is an index-tracking product designed to give investors access to companies seeking growth opportunities where healthcare and technology converge. It captures industry change centered on medical analytics and software, smart medical devices, AI-driven drug discovery and technology-based consumer healthcare.

It suits long-term investors who want diversified exposure to the health tech theme as a whole rather than picking individual medical technology companies.

It is a passively managed (index-tracking) ETF run by Global X.

It is a passive product built to follow the price and return trends of the Global X HealthTech Index. It offers diversified exposure to companies that make heavy use of medical technology, and its portfolio, which includes OSCR, IQV, DXCM, VEEV and GEHC, reflects the intersection of healthcare services and technological change.

• Focus on the intersection of healthcare and technology
• Diversified exposure to global health tech companies

Assets under management (AUM) stand at $32.3M, and the Expense Ratio is 0.50% per year.

Because trading conditions and fee burdens can change over time, the actual trading environment should be checked separately through official disclosures and market quotes.

The performance of the health tech theme is sensitive to demand for medical services, the regulatory environment, the pace of technology adoption and shifts in growth stock valuations. The return pattern of the HEAL ETF therefore reflects both individual industry news and broad stock market swings, and price fluctuations can widen.

Fund flows are influenced by expectations for AI adoption, the spread of digital healthcare and greater efficiency in medical costs, as well as by changes in market risk appetite. However, thematic products can see flows and trading conditions change quickly when market uncertainty rises, so liquidity and bid-ask quotes should be checked together.

The fund offers broad access to structural change in the health tech theme, but it can be strongly affected by individual growth stocks and regulatory variables.

Among the products in the table, the TRFK ETF focuses on the data and digital innovation theme, the PPH ETF on the pharmaceutical industry and the NXTG ETF on changes in telecommunications technology. The CLOU ETF covers cloud computing companies and the WQTM ETF covers quantum computing companies, so they differ from the HEAL ETF in scope, which centers on medical technology. These products are better seen as reference points for comparing sub-areas of the technology theme than as direct health tech substitutes, and data on similar thematic products is limited.

Before approaching the HEAL ETF, investors should check not only the theme's growth potential but also fees, distribution policy, trading conditions and the business characteristics of the holdings. Because it combines healthcare and technology, it can be affected by policy changes and market valuations at the same time.

Because the HEAL ETF concentrates on the medical technology industry, it can be more sensitive than the broader market to changes in industry regulation, research and development, product approvals and insurance systems. Stocks that price in high growth expectations can see wider price swings as earnings and outlooks change, and because the fund holds overseas assets, exchange rate movements also affect performance in Korean won terms.

The HEAL ETF is a passive product suited to investors who want long-term diversified exposure to the convergence of healthcare and technology. However, thematic concentration, trading conditions, exchange rates and fee burden should be compared together, and before investing, holdings and management information in official materials should be reviewed.